Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clearmind Medicine Inc
(NQ:
CMND
)
1.310
-0.070 (-5.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Clearmind Medicine Inc
< Previous
1
2
3
4
5
6
Next >
Could Psychedelics End Binge Drinking? A Breakthrough Patent Says Yes
August 23, 2024
Clearmind Medicine secures a U.S. patent for its MEAI-based binge behavior treatment, marking a significant advancement in addressing Alcohol Use Disorder.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
August 09, 2024
We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns!
Via
InvestorPlace
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
August 09, 2024
Via
Benzinga
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
July 16, 2024
Via
Benzinga
CMND Stock Earnings: Clearmind Medicine Reported Results for Q2 2024
June 17, 2024
Clearmind Medicine just reported results for the second quarter of 2024.
Via
InvestorPlace
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 16, 2024
Via
Benzinga
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
July 16, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Is SciSparc (SPRC) Stock Up 25% Today?
July 16, 2024
SciSparc stock is up on Tuesday as SPRC investors learn of the company filing a new patent covering its weight loss treatment.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Dow Jumps 400 Points; US Retail Sales Flat For June
July 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher
June 28, 2024
Clearmind Medicine shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge behavior regulator program through the granting of patent approval in...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Day Trading My Way From Red To Green
June 23, 2024
I set daily profit goals and max loss limits to manage my risk. My daily goal is $5,000, and I cap my daily loss at the same amount.
Via
Talk Markets
What's Going On With Clearmind Medicine Stock Tuesday?
June 11, 2024
Clearmind said its alcohol substitute was granted patents in the U.S., India and Europe. The company also highlighted that the no/low alcohol category is forecasted to grow at a volume CAGR of more...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Clearmind Medicine Stock Is Moving Higher
May 07, 2024
Clearmind Medicine shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yissum Research Development.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 07, 2024
Via
Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
April 17, 2024
Via
Benzinga
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Via
Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Via
Benzinga
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
March 29, 2024
Via
Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
March 20, 2024
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
Via
Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Via
Benzinga
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
March 12, 2024
Via
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Via
Benzinga
EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
February 27, 2024
Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
February 21, 2024
SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?
February 20, 2024
SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Via
Benzinga
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
February 15, 2024
Via
Benzinga
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 01, 2024
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.